Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan
The Journal of Pediatrics · 2023-02 · 253 · 101-106.e2
DOI: 10.1016/j.jpeds.2022.09.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pediatrics, 2023-02. Verfasst von Eri Hoshino und 8 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan Un…. Hauptthemen laut MEDLINE: Biliary Atresia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the cost-effectiveness of universal newborn screening using stool color card or direct bilirubin (DB) testing when comparing with no screening for biliary atresia in Japanese setting. STUDY DESIGN: A decision analytic Markov microsimulation model was developed to evaluate the universal screening for biliary atresia. Our screening strategies included stool color card, DB, or no screening. The outcomes of all newborns undergoing 3 strategies were simulated to analyze event-free life-years defined as liver transplant-free survival, costs, and incremental cost-effectiveness ratio (ICER) over a 25-year period with an annual discount rate of 2% applied for both costs and outcomes. A 1-way sensitivity analysis was performed to assess the uncertainty. RESULTS: There were 941 000 newborn infants in our cohort and 114 cases of biliary atresia. The base case analysis showed that the stool color card strategy was $14 927 337 higher than no screening with an increase in 44 more event-free life-years gained, resulting in an ICER of $339 258 per event-free life-year gained. The DB screening strategy compared with stool color card was $138 994 060 higher with an increase in 271 more event-free life-years gained and an ICER of $512 893 per event-free life-year gained. The DB screening strategy compared with no screening resulted in an ICER of $488 639 per event-free life-year gained. The DB screening resulted in 16 fewer liver transplants than stool color card and stool color card had 2 fewer liver transplants than no screening. CONCLUSIONS: Universal screening for biliary atresia could be cost-effective depending on the willingness to pay thresholds for health benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan University, Kyoto, Japan; Graduate School of Public Health, St. Luke's I…
- Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan University, Kyoto, Japan.
- Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Center for Outcomes Research and Economic Evaluation for Health (C2H), National Institute of Public Health, Kyoto, Japan.
- Graduate School of Public Health, St. Luke's International University, Kyoto, Japan; Department of Social Medicine, National Center for Child Health and Development, Kyoto, Japan.
- Department of Pediatrics, Faculty of Medicine, Juntendo University, Kyoto, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Hoshino, E., Moriwaki, K., Morimoto, K., Sakai, K., Shimohata, N., Konomura, K., Urayama, K. Y., Suzuki, M., & Shimozuma, K. (2023). Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan. The Journal of Pediatrics, 253, 101-106.e2. https://doi.org/10.1016/j.jpeds.2022.09.028
Vancouver
Hoshino E, Moriwaki K, Morimoto K, Sakai K, Shimohata N, Konomura K, et al. Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan. The Journal of Pediatrics. 2023;253:101-106.e2. doi:10.1016/j.jpeds.2022.09.028
BibTeX
@article{Hoshino2023,
author = {Hoshino, Eri and Moriwaki, Kensuke and Morimoto, Kosuke and Sakai, Kotomi and Shimohata, Nobuyuki and Konomura, Keiko and Urayama, Kevin Y and Suzuki, Mitsuyoshi and Shimozuma, Kojiro},
title = {Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan},
journal = {The Journal of Pediatrics},
year = {2023},
volume = {253},
pages = {101--106.e2},
doi = {10.1016/j.jpeds.2022.09.028}
}
EUVIMED